National Institute on Minority Health and Health Disparities; Notice of Meeting, 39107-39108 [2018-16976]
Download as PDF
<![CDATA[
Federal Register / Vol. 83, No. 153 / Wednesday, August 8, 2018 / Notices
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
sradovich on DSK3GMQ082PROD with NOTICES
Name of Committee: National Advisory
Council for Nursing Research.
Date: September 4–5, 2018.
Open: September 4, 2018, 1:00 p.m. to 5:00
p.m.
Agenda: Discussion of Program Policies
and Issues.
Place: National Institutes of Health,
Building 31, 6th Floor, C Wing, Room 6, 31
Center Drive, Bethesda, MD 20892.
Closed: September 5, 2018, 9:00 a.m. to
1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 6th Floor, C Wing, Room 6, 31
Center Drive, Bethesda, MD 20892.
Contact Person: Marguerite Littleton
Kearney, Director Division of Extramural
Science Programs, National Institute of
Nursing Research National Institutes of
Health, 6701 Democracy Boulevard, Room
708, Bethesda, MD 20892, 301–402–7932,
marguerite.kearnet@nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.ninr.nih.gov/aboutninr/nacnr, where an
agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.361, Nursing Research,
National Institutes of Health, HHS).
Dated: August 3, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–16978 Filed 8–7–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
NIH Clinical Center Research Hospital
Board; Notice of Charter Renewal
In accordance with Title 41 of the
U.S. Code of Federal Regulations,
Section 102–3.65(a), notice is hereby
given that the Charter for the NIH
Clinical Center Research Hospital Board
was renewed for an additional two-year
period on May 29, 2018.
It is determined that the NIH Clinical
Center Research Hospital Board is in the
public interest in connection with the
performance of duties imposed on the
National Institutes of Health by law, and
that these duties can best be performed
through the advice and counsel of this
group.
Inquiries may be directed to Claire
Harris, Acting Director, Office of Federal
Advisory Committee Policy, Office of
the Director, National Institutes of
Health, 6701 Democracy Boulevard,
Suite 1000, Bethesda, Maryland 20892
(Mail Stop Code 4875), harriscl@nih.gov
or Telephone (301) 496–2123.
Dated: August 2, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–16979 Filed 8–7–18; 8:45 am]
BILLING CODE 4140–01–P
22:37 Aug 07, 2018
Jkt 244001
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Paul A. Amstad, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
Room 3G41, NIAID/NIH/DHHS, 5601 Fishers
Lane, Bethesda, MD 20892–7616, 240–669–
5067, pamstad@niaid.nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Investigator Initiated
Clinical Trial Planning and Implementation
Applications.
Date: September 24, 2018.
Time: 12:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Lynn Rust, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
Room 3G42A, National Institutes of Health/
NIAID, 5601 Fishers Lane, MSC 9823,
Bethesda, MD 20892–9823, (240) 669–5069,
lrust@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: August 3, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–16974 Filed 8–7–18; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4140–01–P
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Cooperative Centers on
Human Immunology.
Date: September 5–11, 2018.
VerDate Sep<11>2014
39107
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
National Institutes of Health
National Institute on Minority Health
and Health Disparities; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
Council on Minority Health and Health
Disparities.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
E:\FR\FM\08AUN1.SGM
08AUN1
39108
Federal Register / Vol. 83, No. 153 / Wednesday, August 8, 2018 / Notices
sradovich on DSK3GMQ082PROD with NOTICES
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council on Minority Health and Health
Disparities.
Date: September 6–7, 2018.
Closed: September 6, 2018, 1:30 p.m. to
adjournment.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive,
Conference Rooms E1 and E2, Bethesda, MD
20892.
Open: September 7, 2018, 8:00 a.m. to
12:00 p.m.
Agenda: The agenda will include opening
remarks, administrative matters, Director’s
report, NIH Health Disparities update, and
other business of the Council.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive,
Conference Rooms E1 and E2, Bethesda, MD
20892.
Contact Person: Dr. Joyce A. Hunter,
Deputy Director, NIMHD, National Institutes
of Health, National Institute on Minority
Health and Heath Disparities, 6707
Democracy Blvd., Suite 800, Bethesda, MD
20892, (301) 402–1366, hunterj@nih.gov.
Any member of the public interested in
presenting oral comments to the committee
may notify the Contact Person listed on this
notice at least 10 days in advance of the
meeting. Interested individuals and
representatives of organizations may submit
a letter of intent, a brief description of the
organization represented, and a short
description of the oral presentation. Only one
representative of an organization may be
allowed to present oral comments and if
accepted by the committee, presentations
may be limited to five minutes. Both printed
and electronic copies are requested for the
record. In addition, any interested person
may file written comments with the
committee by forwarding their statement to
the Contact Person listed on this notice. The
statement should include the name, address,
telephone number and when applicable, the
business or professional affiliation of the
interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus.
All visitor vehicles, including taxis, hotel,
and airport shuttles, will be inspected before
being allowed on campus. Visitors will be
asked to show one form of identification (for
example, a government-issued photo ID,
driver’s license, or passport) and to state the
purpose of their visit.
VerDate Sep<11>2014
22:37 Aug 07, 2018
Jkt 244001
Dated: August 2, 2018.
David D. Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–16976 Filed 8–7–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Arthritis and
Musculoskeletal and Skin Diseases
Advisory Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Arthritis and
Musculoskeletal and Skin Diseases Advisory
Council.
Date: September 5, 2018.
Open: 8:30 a.m. to 12:00 p.m.
Agenda: To discuss program policies and
issues.
Place: National Institutes of Health,
Building 31, Rm: 6C10, 31 Center Drive,
Bethesda, MD 20892.
Closed: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, Rm: 6C10, 31 Center Drive,
Bethesda, MD 20892.
Contact Person: Melinda Nelson, Acting
Director, National Institute of Arthritis and
Musculoskeletal and Skin Diseases, Grants
Management Branch, 45 Center Drive, Room
5A49, Bethesda, MD 20892, (301) 594–3535,
mn23z@nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
Dated: August 3, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–16975 Filed 8–7–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Minority Health
and Health Disparities; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Minority Health and Health Disparities;
Special Emphasis Panel; Review of R01
Applications in Response to RFA–MD–18–
005, ‘‘Youth Violence Prevention
Interventions’’.
Date: October 19, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications (Teleconference).
Place: National Institutes of Health,
Gateway Plaza, 7201 Wisconsin Ave,
Bethesda, MD 20817.
Contact Person: Deborah Ismond, Ph.D.,
Scientific Review Officer, Division of
Scientific Programs, National Institute on
Minority Health and Health Disparities,
National Institutes of Health, 7201 Wisconsin
Ave., Suite 525, Bethesda, MD 20814, (301)
594–2704, ismonddr@mail.nih.gov.
E:\FR\FM\08AUN1.SGM
08AUN1
]]>Agencies
[Federal Register Volume 83, Number 153 (Wednesday, August 8, 2018)]
[Notices]
[Pages 39107-39108]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-16976]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Minority Health and Health Disparities;
Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Advisory
Council on Minority Health and Health Disparities.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C.,
[[Page 39108]]
as amended. The grant applications and/or contract proposals and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications and/or
contract proposals, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Advisory Council on Minority Health
and Health Disparities.
Date: September 6-7, 2018.
Closed: September 6, 2018, 1:30 p.m. to adjournment.
Agenda: To review and evaluate grant applications and/or
proposals.
Place: National Institutes of Health, Natcher Building, 45
Center Drive, Conference Rooms E1 and E2, Bethesda, MD 20892.
Open: September 7, 2018, 8:00 a.m. to 12:00 p.m.
Agenda: The agenda will include opening remarks, administrative
matters, Director's report, NIH Health Disparities update, and other
business of the Council.
Place: National Institutes of Health, Natcher Building, 45
Center Drive, Conference Rooms E1 and E2, Bethesda, MD 20892.
Contact Person: Dr. Joyce A. Hunter, Deputy Director, NIMHD,
National Institutes of Health, National Institute on Minority Health
and Heath Disparities, 6707 Democracy Blvd., Suite 800, Bethesda, MD
20892, (301) 402-1366, [email protected].
Any member of the public interested in presenting oral comments
to the committee may notify the Contact Person listed on this notice
at least 10 days in advance of the meeting. Interested individuals
and representatives of organizations may submit a letter of intent,
a brief description of the organization represented, and a short
description of the oral presentation. Only one representative of an
organization may be allowed to present oral comments and if accepted
by the committee, presentations may be limited to five minutes. Both
printed and electronic copies are requested for the record. In
addition, any interested person may file written comments with the
committee by forwarding their statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus.
All visitor vehicles, including taxis, hotel, and airport
shuttles, will be inspected before being allowed on campus. Visitors
will be asked to show one form of identification (for example, a
government-issued photo ID, driver's license, or passport) and to
state the purpose of their visit.
Dated: August 2, 2018.
David D. Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-16976 Filed 8-7-18; 8:45 am]
BILLING CODE 4140-01-P
